SOBRAFO Farmácia Oncológica common mistakes
SOBRAFO Farmácia Oncológica · Understand the traps and how to avoid them.
Memorizing antineoplastic drug names in isolation and selecting a mechanism or class (e.g., alkylating vs. antimetabolite vs. topoisomerase inhibitor) from vague recall of the name rather than from its structural/functional class.
Candidates often learn drug lists by rote for the exam and never build a class-based framework, so under time pressure they pattern-match on name familiarity and confuse drugs with similar names or overlapping indications.
What to do instead
Build a one-page class map (alkylators, antimetabolites, topoisomerase I/II inhibitors, tubulin binders, antibiotic antitumorals, targeted agents by pathway) and for each drug write its class, primary mechanism, cell-cycle phase specificity, and hallmark toxicity; self-test by covering the drug name and deriving it from the class descriptor.
Calculating cytotoxic doses from body surface area or AUC without verifying the protocol-specified cap, dose rounding rule, or renal/hepatic adjustment, and proceeding with the raw calculated number.
Candidates treat dose calculation as a pure arithmetic exercise and forget that real protocols specify maximum doses, dose banding, and organ-function-based modifications; the arithmetic looks 'correct' so the error is invisible.
What to do instead
Adopt a fixed verification sequence for every calculation item: confirm protocol and cycle, confirm BSA/weight basis and whether ideal or actual weight applies, apply the dose cap, apply organ-function adjustment, then perform an independent recalc; practice on items where the naive answer is deliberately wrong because a cap or adjustment was omitted.
Treating hazardous-drug handling as generic clean technique, answering questions about PPE, closed-system transfer devices, and biological safety cabinets with the same rules as routine compounding.
Candidates conflate sterile compounding standards with hazardous-drug standards and underestimate how much of the exam tests specific engineering controls, PPE sequencing, and spill/deactivation procedures rather than aseptic technique alone.
What to do instead
Study hazardous handling as its own system: engineering controls (ventilated cabinet, CSTD), PPE (gown, gloves, eye/face protection, respirator where indicated), work-surface and final decontamination, spill kit use, and waste segregation by hazard class; rehearse the sequence as an ordered checklist so items about 'what comes first' resolve correctly.
Selecting an antiemetic or supportive-care regimen based on the emetogenic class of the drug alone, ignoring patient-specific emetic risk factors and the protocol's specified prophylaxis schedule.
Candidates memorize emetogenicity tables but not the risk-factor modifiers and schedule timing, so they choose a plausible-sounding regimen that is under- or over-prophylaxed for the described patient.
What to do instead
For each case, state the emetogenic class, list patient risk factors (age, sex, prior emesis, anxiety, alcohol history), then match to the guideline-consistent prophylaxis combination and timing (acute vs. delayed phase); practice distinguishing 'rescue' from 'prophylaxis' in item stems.
Reading an adverse-effect item as a request to name the toxicity rather than to identify the immediate management or the drug most likely responsible, and answering with the diagnosis only.
Stems often describe a syndrome and ask for the next action or the causative agent; candidates anchor on the diagnosis they recognize and stop reading the actual question.
What to do instead
Underline the interrogative in every item before answering (mechanism, monitoring, management, causative drug, contraindication) and force yourself to write the requested category next to your answer; drill mixed sets where the same vignette is asked four different ways.
Applying general adult oncology dosing and monitoring to special populations (older adults, renal or hepatic impairment, obesity, pregnancy/lactation) using standard protocols without modification.
Candidates learn one canonical regimen per cancer type and do not practice the population-specific adjustments, so they default to the standard dose in vignettes designed to test modification.
What to do instead
Create a special-populations matrix per major drug (renal elimination fraction, hepatic metabolism, whether dose reduction or avoidance applies, geriatric assessment considerations) and practice vignettes that explicitly state creatinine clearance, bilirubin, or frailty so the adjustment becomes automatic.
Confusing tumor biology concepts such as driver mutation versus passenger mutation, tumor suppressor versus oncogene, and staging versus grading when answering fundamentals items.
These terms are learned as vocabulary lists rather than as causal models, so candidates pick the option that sounds most sophisticated rather than the one that fits the described biology.
What to do instead
Write short causal explanations for each pair (what happens when the gene is overactive versus lost, what a driver alteration implies for targeted therapy selection, what stage versus grade predicts) and test yourself by explaining a described tumor in plain language before looking at options.
Answering pharmacovigilance and clinical-trial items by describing the general purpose of reporting instead of applying the specific seriousness, expectedness, causality, and reporting-timeline criteria.
Candidates know that adverse events should be reported but not the operational decision tree, so they give a correct-sounding but non-specific answer that misses the classification the item is testing.
What to do instead
Memorize and rehearse the decision tree: is it an adverse event or serious adverse event, is it expected per the investigator brochure or label, what is the causality assessment, and what is the reporting route and timeline; practice classifying short scenarios into the correct category before choosing an option.
Treating ethics and legal items as common-sense questions, answering from personal opinion about confidentiality, informed consent, or dispensing authority rather than from the governing professional and legal framework.
Candidates assume ethics items have obvious answers and do not review the specific legal duties, documentation requirements, and scope-of-practice boundaries that the exam actually tests.
What to do instead
Build a concise reference of the legal and ethical duties relevant to oncology pharmacy (informed consent elements, confidentiality and record handling, prescription and dispensing requirements, error and near-miss reporting obligations, conflict-of-interest and research-ethics rules) and answer ethics items by citing the specific duty rather than a general principle.
Skipping the pharmaceutical care process in patient-centered items, giving a drug recommendation without documenting the problem list, monitoring parameters, or follow-up plan.
Candidates equate clinical knowledge with giving the right drug and do not practice structuring an answer around assessment, plan, monitoring, and education, which is what patient-care items reward.
What to do instead
Practice writing SOAP-style responses for oncology vignettes that always include the identified drug-related problem, the intervention, the monitoring parameters with frequency, and the patient education points; check that every patient-care answer names at least one measurable follow-up parameter.